Enoxaparin once daily vs. twice daily dosing for the treatment of venous thromboembolism in cancer patients: A literature summary

Current anticoagulation guidelines for cancer patients are largely based upon studies done in the general population. Anticoagulation studies in cancer patients with venous thromboembolism (VTE) have compared varying doses of different low molecular weight heparins (LMWH) to warfarin or unfractionat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Oncology Pharmacy Practice 2012-06, Vol.18 (2), p.264-270
Hauptverfasser:	Diaz, Amber H, Rodgers, George M, Gilreath, Jeffrey A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Cancer Clinical Trials as Topic - methods Drug Administration Schedule Enoxaparin - administration & dosage Humans Neoplasms - drug therapy Neoplasms - epidemiology Oncology Pharmacology Risk factors Side effects Treatment Outcome Venous Thromboembolism - drug therapy Venous Thromboembolism - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!